DOJ's Bureau of Prisons awards $2.24M for 2026-27 flu vaccine to Sanofi
Contract Overview
Contract Amount: $2,242 ($2.2K)
Contractor: Sanofi Vaccines US Inc.
Awarding Agency: Department of Justice
Start Date: 2026-04-07
End Date: 2026-09-30
Contract Duration: 176 days
Daily Burn Rate: $13/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: STAFF ONLY INFLUENZA VIRUS VACCINE 2026-2027 CONTRACT #: 36E79726D0009
Place of Performance
Location: SWIFTWATER, MONROE County, PENNSYLVANIA, 18370
Plain-Language Summary
Department of Justice obligated $2,241.6 to SANOFI VACCINES US INC. for work described as: STAFF ONLY INFLUENZA VIRUS VACCINE 2026-2027 CONTRACT #: 36E79726D0009 Key points: 1. Contract awarded to Sanofi Vaccines US Inc. for $2.24 million. 2. The contract is for the 2026-2027 influenza virus vaccine. 3. Competition method was 'Full and Open', suggesting a competitive bidding process. 4. The sector is Pharmaceutical Preparation Manufacturing.
Value Assessment
Rating: good
The award amount of $2.24 million for a single delivery order appears reasonable for a national vaccine supply. Benchmarking against similar large-scale vaccine procurements would provide further validation.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The 'Full and Open Competition' method indicates that multiple vendors had the opportunity to bid, which typically drives competitive pricing. The final price reflects the outcome of this competitive process.
Taxpayer Impact: The $2.24 million expenditure is for essential healthcare services, aiming to protect federal inmates and staff, representing a necessary investment in public health within the correctional system.
Public Impact
Ensures availability of flu vaccine for federal prison system staff. Supports public health initiatives within correctional facilities. Contributes to preventing outbreaks and maintaining operational stability in prisons.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for price fluctuations in future vaccine procurements.
- Dependence on a single supplier for a critical health commodity.
Positive Signals
- Proactive procurement for upcoming flu season.
- Use of full and open competition promotes fair pricing.
Sector Analysis
The pharmaceutical preparation manufacturing sector is highly regulated and subject to significant R&D costs and market competition. Spending on vaccines is a critical component of public health infrastructure.
Small Business Impact
The contract was awarded to a large corporation, Sanofi Vaccines US Inc. There is no indication of specific provisions or set-asides for small businesses in this particular award.
Oversight & Accountability
The Department of Justice, through the Bureau of Prisons, is responsible for this procurement. Standard oversight mechanisms for federal contracts, including performance monitoring and financial accountability, would apply.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Justice Contracting
- Federal Prison System / Bureau of Prisons Programs
Risk Flags
- Potential for price increases in future contract periods.
- Supply chain vulnerability for critical pharmaceutical products.
- Limited visibility into per-unit cost due to firm fixed price nature.
- Dependence on a single awardee for a specific flu season.
Tags
pharmaceutical-preparation-manufacturing, department-of-justice, pa, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $2,241.6 to SANOFI VACCINES US INC.. STAFF ONLY INFLUENZA VIRUS VACCINE 2026-2027 CONTRACT #: 36E79726D0009
Who is the contractor on this award?
The obligated recipient is SANOFI VACCINES US INC..
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $2,241.6.
What is the period of performance?
Start: 2026-04-07. End: 2026-09-30.
What is the historical pricing trend for this specific vaccine or similar influenza vaccines procured by the government?
Analyzing historical pricing data for this vaccine or comparable influenza vaccines procured by federal agencies would reveal if the current $2.24 million award represents a fair market price or if there's an upward or downward trend. This context is crucial for assessing long-term value and identifying potential cost-saving opportunities in future solicitations.
What are the specific risks associated with relying on Sanofi for this critical vaccine supply for the federal prison system?
Risks include potential supply chain disruptions, manufacturing issues, or unforeseen demand surges that could impact delivery timelines. Dependence on a single supplier, even through competitive bidding, can create vulnerabilities. The government should have contingency plans in place, such as identifying alternative suppliers or maintaining strategic stockpiles.
How effectively does this vaccine procurement contribute to the overall health and safety goals of the Federal Prison System?
This procurement directly supports the health and safety goals by providing essential protection against influenza for staff and potentially inmates. Preventing widespread illness reduces healthcare burdens within facilities, minimizes disruptions to operations, and contributes to a safer environment. The effectiveness is measured by vaccine uptake and reduction in flu-related incidents.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Sanofi
Address: 1 DISCOVERY DR, SWIFTWATER, PA, 18370
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $2,242
Exercised Options: $2,242
Current Obligation: $2,242
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 36E79726D0009
IDV Type: IDC
Timeline
Start Date: 2026-04-07
Current End Date: 2026-09-30
Potential End Date: 2026-09-30 00:00:00
Last Modified: 2026-04-07
More Contracts from Sanofi Vaccines US Inc.
- 00hcvgbc-2009-68767 - Sanofi VFC Pediatric Vaccine Contract — $737.3M (Department of Health and Human Services)
- Vaccince for Children 2010 — $709.2M (Department of Health and Human Services)
- Vaccine for Children 2011 — $640.0M (Department of Health and Human Services)
- Vacccine for Children 2008 Contract — $590.5M (Department of Health and Human Services)
- VFC 2012 — $589.8M (Department of Health and Human Services)
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)